CVE-2023-20229

Katalog CVE

CVSS 7.1 · High EPSS 0,41%

Kerentanan Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') pada cisco duo device health application. Skor CVSS 3.1 7.1 (High) menurut NVD.

Deskripsi (NVD)

A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.

Rincian

Terbit di NVD

16 Agustus 2023

Terakhir diubah

17 Juni 2026

Status NVD

Modified

CVSS 3.1

7.1 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H · uraikan di kalkulator

Jenis kelemahan (CWE)

CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

EPSS (30 hari)

0,41% peluang dieksploitasi; lebih tinggi dari 33,3% CVE lain

Produk dan versi terdampak

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

• https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-duo-dha-filewrite-xPMBM... patch · advisory vendor